Patient-reported outcomes for patients with locally advanced or metastatic urothelial carcinoma under pembrolizumab: A prospective multicenter observational study.

被引:0
|
作者
Annakib, Soufyan
Bekoy, Yona Dibert
Chevallier, Thierry
Fiteni, Frederic
Houede, Nadine
机构
[1] CHU Nimes, ICG, Nimes, France
[2] Univ Montpellier, CHU Nimes, Dept Biostat Epidemiol Publ Hlth & Innovat Method, Nimes, France
[3] CHU Nimes, Nimes, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
490
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Quality of life patient-reported outcomes for locally advanced cutaneous melanoma
    Weitman, Evan S.
    Perez, Matthew
    Thompson, John F.
    Andtbacka, Robert H. I.
    Dalton, Jo
    Martin, Mona L.
    Miller, Talia
    Gwaltney, Chad
    Sarson, David
    Wachter, Eric
    Zager, Jonathan S.
    MELANOMA RESEARCH, 2018, 28 (02) : 134 - 142
  • [42] Atezolizumab for locally advanced/metastatic urothelial carcinoma within the compassionate use program in Spain: The IMcompass study.
    Duran, Miguel Angel A. Climent
    Perez-Gracia, Jose Luis
    Arija, Jose Angel Arranz
    Alvarez-Fernandez, Carlos
    Mediavilla, Jenifer Gomez
    Rodriguez, Angel
    Vazquez-Estevez, Sergio
    Jurado, Jose Miguel
    Santander, Carmen
    Bonfill, Teresa
    Palau, Carmen Molins
    Ramirez, Sara Perez
    Caceres, Paola Pimentel
    Arnaiz, Pablo
    Garate, Zita
    Soto, Atenea
    Puente, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [43] A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application
    David Richardson
    Lin Zhan
    Reshma Mahtani
    Lynn McRoy
    Debanjali Mitra
    Maria Reynolds
    Dawn Odom
    Kelly Hollis
    James A. Kaye
    Cheryl Jones
    Jeffrey Hargis
    Breast Cancer Research and Treatment, 2021, 187 : 113 - 124
  • [44] A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application
    Richardson, David
    Zhan, Lin
    Mahtani, Reshma
    McRoy, Lynn
    Mitra, Debanjali
    Reynolds, Maria
    Odom, Dawn
    Hollis, Kelly
    Kaye, James A.
    Jones, Cheryl
    Hargis, Jeffrey
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (01) : 113 - 124
  • [45] Efficacy, Safety, and Patient-Reported Outcomes of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Thailand: A Multicenter Prospective Study
    Charonpongsuntorn, Chanchai
    Tanasanvimon, Suebpong
    Korphaisarn, Krittiya
    Payapwattanawong, Songwit
    Siripoon, Teerada
    Pakvisal, Nussara
    Juengsamarn, Jitlada
    Phaibulvatanapong, Ekkamol
    Chindaprasirt, Jarin
    Prasongsook, Naiyarat
    Udomdamrongkul, Kittipong
    Ngamphaiboon, Nuttapong
    Sirachainan, Ekaphop
    JCO GLOBAL ONCOLOGY, 2022, 8 : e2200205
  • [46] Futibatinib plus pembrolizumab in patients (pts) with advanced or metastatic urothelial carcinoma (mUC): Preliminary safety results from a phase 2 study.
    Koshkin, Vadim S.
    Sonpavde, Guru P.
    Hwang, Clara
    Mellado, Begona
    Tomlinson, Gareth
    Shimura, Masashi
    Chisamore, Michael Jon
    Gil, Maciej
    Loriot, Yohann
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [47] Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
    Martin, Susan
    Shah, Sonali N.
    Hepp, Zsolt
    Harris, Nimanee
    Morgans, Alicia K.
    BLADDER CANCER, 2022, 8 (01) : 45 - 53
  • [48] Quality of life in patients with metastatic renal cell carcinoma: The importance of patient-reported outcomes
    Cella, David
    CANCER TREATMENT REVIEWS, 2009, 35 (08) : 733 - 737
  • [49] Patient-reported outcomes in a randomized trial of everolimus with metastatic renal cell carcinoma patients
    Beaumont, J.
    Cella, D.
    Hutson, T.
    Bracarda, S.
    Gruenwald, V.
    Thompson, J.
    Ravaud, A.
    Urbanowitz, G.
    Hollaender, N.
    Motzer, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Patient-reported outcomes in patients with primary immunodeficiency diseases in Japan: baseline results from a prospective observational study
    Kanegane, Hirokazu
    Ishimura, Masataka
    Kawai, Toshinao
    Okada, Satoshi
    Okamatsu, Nobuaki
    Go, Madoka
    Noto, Shinichi
    FRONTIERS IN IMMUNOLOGY, 2023, 14